We demonstrated recently that in Chinese hamster ovary cells stably expressing human recombinant endothelin A receptors (CHO-ET A R), endothelin-1 (ET-1) activates two types of Ca 2ϩ -permeable nonselective cation channels (designated NSCC-1 and NSCC-2) and a store-operated Ca 2ϩ channel (SOCC), which can be distinguished by Ca 2ϩ channel blockers such as 1-{␤-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenylethyl}-1H-imidazole hydrochloride (SK&F 96365) and (R,S)-(3,4-dihydro-6,7-dimethoxy-isochinolin-1-yl)-2-phenyl-N,N-di[2-(2,3,4-trimethoxyphenyl)ethyl]acetamid mesylate (LOE 908). We also reported that CHO-ET A R couples with G 12 in addition to G q and G s . The purpose of the present study was to identify the G proteins involved in the activation of these Ca 2ϩ channels by ET-1, using mutated ET A Rs with coupling to either G q or G s /G 12 (designated ET A R⌬385 and SerET A R, respectively) and a dominant-negative mutant of G 12 (G 12 G228A). ET A R⌬385 is truncated immediately downstream of Cys 385 in the C terminus as palmitoylation sites, whereas SerET A R is unpalmitoylated because of substitution of all the cysteine residues to serine (Cys 383 Cys 385-388 3 Ser 383 Ser 385-388 ). In CHO-ET A R⌬385, stimulation with ET-1 activated only SOCC. In CHO-SerET A R or CHO-ET A R pretreated with U73122, an inhibitor of phospholipase C (PLC), ET-1 activated only NSCC-1. Dibutyryl cAMP alone did not activate any Ca 2ϩ channels in the resting and ET-1-stimulated CHO-SerET A R. Microinjection of G 12 G228A abolished the activation of NSCC-1 and NSCC-2 in CHO-ET A R and that of NSCC-1 in CHO-SerET A R. These results indicate that ET A R activates three types of Ca 2ϩ channels via different G protein-related pathways. NSCC-1 is activated via a G 12 -dependent pathway, NSCC-2 via G q /PLC-and G 12 -dependent pathways, and SOCC via a G q /PLC-dependent pathway.
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Endothelin-1 (ET-1), a 21-amino acid peptide, is one of the most potent endogenous vasoconstricting agents (Yanagisawa et al., 1988 ). Subsequent studies have described its multiple and wide-ranging biological activities, including modulation of neurotransmission (Koseki et al., 1989 ) and stimulation of cell proliferation (Komuro et al., 1988; Shichiri et al., 1991) . Recent reports have demonstrated that extracellular Ca 2ϩ influx through voltage-independent Ca 2ϩ channels (VICCs) plays a critical role for ET-1-induced contraction of rat aorta (Zhang et al., 1999) and ET-1-induced proliferation of vascular smooth muscle cells (VSMCs) (Kawanabe et al., 2002a) . Thus, it is important to elucidate activation mechanisms of VICCs by ET-1. Biological actions of ET-1 are mediated by two distinct receptor subtypes: endothelin A and endothelin B receptors (ET A Rs and ET B Rs, respectively), which belong to a family of G protein-coupled receptors (Arai et al., 1990; Sakurai et al., 1990) . Therefore, in the present study, we focused on investigating which G protein subtypes were involved in the activation of each Ca 2ϩ channel by ET-1. Transfection and functional expression of wild-type or mutant ET A R cDNAs into the same cell type provides a model This work was supported by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, by Special Coordination Funds for Science and Technology from the Science and Technology Agency, by a research grant for cardiovascular disease (11C-1) from the Ministry of Health and Welfare, and by a grant from the Smoking Research Foundation, Japan.
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ET-1, endothelin-1; VICC, voltage-independent Ca 2ϩ channel; VSMC, vascular smooth muscle cell; ET A R, endothelin A receptor; ET B R, endothelin B receptor; CHO, Chinese hamster ovary; NSCC, nonselective cation channel; SOCC, store-operated Ca 2ϩ channel; PLC, phospholipase C; SK&F 96365, 1-{␤-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenylethyl}-1H-imidazole hydrochloride; LOE 908, (R,S)-(3,4-dihydro-6,7-dimethoxy-isochinolin-1-yl)-2-phenyl-N,N-di [2-(2,3,4-trimethoxyphenyl) (Kawanabe et al., 2001) . In particular, these channels can be distinguished using Ca 2ϩ channel blockers such as SK&F 96365 and LOE 908. Thus, NSCC-1 is sensitive to LOE 908 and resistant to SK&F 96365, NSCC-2 is sensitive to both LOE 908 and SK&F 96365, and the SOCC is resistant to LOE 908 and sensitive to SK&F 96365 (Kawanabe et al., 2001 ). The VICCs activated by ET-1 in CHO-ET A R are pharmacologically identical to those in VSMCs (Kawanabe et al., 2002a) . Therefore, CHO-ET A R may be a good model for studying the mechanism of activation of VICCs. ET A Rs are functionally coupled with G q and G s in CHO cells (Aramori and Nakanishi, 1992) . Activation of G q and G s causes stimulation of phospholipase C (PLC) and adenylyl cyclase, respectively (Aramori and Nakanishi, 1992) . In addition, ET A Rs also couple with G 12 via its C terminus to induce actin stress fiber formation in CHO cells (Kawanabe et al., 2002b) . In the present study, we used a dominant-negative mutant of G 12 and two types of mutated ET A Rs designated ET A R⌬385 and SerET A R to clarify the involvement of G q , G s , and G 12 for Ca 2ϩ channel activation by ET-1. ET A R⌬385 lacks a C terminus downstream of Cys 385 and couples only with G q in CHO cells (Kawanabe et al., 2002b) . SerET A R is unpalmitoylated because of substitution of all the cysteine residues to serine (Cys 383 Cys 385-388 3 Ser 383 Ser [385] [386] [387] [388] ) and couples with G s and G 12 in CHO cells (Kawanabe et al., 2002b) .
Experimental Procedures
Cell Culture. We used CHO-ET A R, CHO-ET A R⌬385, and CHOSerET A R, which were constructed as described previously (Kawanabe et al., 2002b) . The K d (picomolar) and B max (picomoles per milligram of protein) values for CHO-ET A R, CHO-ET A R⌬385, and CHO-SerET A R were 52.8 Ϯ 2.4 and 1.08 Ϯ 0.16, 49.5 Ϯ 4.3 and 1.12 Ϯ 0.08, and 70.2 Ϯ 4.4 and 1.04 Ϯ 0.14, respectively. CHO cells were maintained in Ham's F12 medium supplemented with 10% fetal calf serum under a humidified 5% CO 2 /95% air atmosphere.
Measurement of Intracellular Free Ca

2؉
Concentration.[Ca 2ϩ ] i was measured using the fluorescent probe fluo-3. The measurement of fluorescence by a CAF 110 spectrophotometer (Jasco, Tokyo, Japan) was performed as described previously (Kawanabe et al., 2001) .
Microfluorimetry of fluo-3 was performed as described previously (Zhang et al., 1999) . Briefly, the cells seeded on 35-mm glass-bottomed plastic dishes (MatTek, Ashland, MA), which were marked with a cross to facilitate the localization of injected cells, were loaded with fluo-3 by incubating them with Ca 2ϩ -free Krebs-HEPES solution containing 10 M fluo-3/AM for 30 min at 37°C under a reduced light. Ca 2ϩ -free Krebs-HEPES solution contained 140 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 11 mM glucose, and 10 mM HEPES, pH 7.4, adjusted with NaOH. After washing with Krebs-HEPES solution (2.2 mM CaCl 2 was added to Ca 2ϩ -free Krebs-HEPES solution), they were kept in fresh Krebs-HEPES solution at 37°C for at least 30 min. Fluo-3 microfluorimetry was performed at 25°C by use of an Attofluor Ratio-Vision real-time digital fluorescence analyzer (Atto Instruments, Rockville, MD) equipped with an Axiovert-100 inverted epifluorescent microscope (Carl Zeiss Inc., Thornwood, NY). A 100-W mercury lamp served as the source of excitation. For measurement of [Ca 2ϩ ] i , fluo-3 was excited at 450 to 490 nm, and fluorescence was detected at 515 to 565 nm. At the end of the experiment, ionomycin and subsequently EGTA were added at final concentrations of 10 M and 10 mM, respectively, to obtain the fluorescence intensity maximum (F max ) and the fluorescence intensity minimum (F min ). [Ca 2ϩ ] i was determined from the equilibrium equation [Ca 2ϩ 
, where F was the experimental value of fluorescence and K d was defined as 0.4 M (Minta et al., 1989) .
Microinjection. For microinjection, cells were seeded onto glass coverslips coated with fibronectin (Iwaki Glass, Chiba, Japan), which were marked with a cross to facilitate the localization of injected cells, and were incubated overnight in Ham's F12 medium containing 1% fetal calf serum. Microinjection of G 12 G228A, constructed as described previously (Kawanabe et al., 2002b) , was performed using a Zeiss microinjection system (Carl Zeiss). Plasmid (100 ng/l) was used for microinjection into the cell nuclei.
Materials. Boehringer Ingelheim GmbH (Ingelheim, Germany) kindly provided LOE 908. Other chemicals were obtained commercially from the following sources: ET-1 from Peptide Institute (Osaka, Japan); SK&F 96365 from Biomol Research Laboratories (Plymouth Meeting, PA); fluo-3/AM from Dojin Laboratories (Kumamoto, Japan); and U73122 from Funakoshi (Tokyo, Japan).
Statistical Analysis. All results were expressed as mean Ϯ S.E.M.
Results
Basic Properties of the ET-1-Induced Increase in [Ca 2؉ ] i in CHO-ET A R, CHO-ET A R⌬385
, and CHO-SerE-T A R. ET-1 induced a biphasic increase in [Ca 2ϩ ] i in CHO-ET A R, consisting of an initial transient phase and a subsequent sustained phase (Fig. 1A) . Both the transient and sustained increase in [Ca 2ϩ ] i were dependent on the concentrations of ET-1 with EC 50 values of approximately 1 nM, and they reached the maximal value at concentrations Ն10 nM (Fig. 1, D 
and E).
In CHO-ET A R⌬385, which is coupled with G q alone, ET-1 also induced a biphasic increase in [Ca 2ϩ ] i (Fig. 1B) . ET-1 caused a transient peak and subsequent sustained increase in [Ca 2ϩ ] i (Fig. 2B ). The magnitude of the transient increase in [Ca 2ϩ ] i in CHO-ET A R⌬385 was essentially similar to that in CHO-ET A R (Fig. 1D) . On the other hand, the magnitude of the sustained increase in [Ca 2ϩ ] i in CHO-ET A R⌬385 was lower than that in CHO-ET A R (Fig. 1E) . Moreover, an ET-1 concentration Ն 10 nM induced a sustained increase in [Ca 2ϩ ] i in CHO-ET A R⌬385, whereas ET-1 induced an increase at only 0.1 nM in CHO-ET A R (Fig. 1E) .
In CHO-SerET A R, which is coupled with G s and G 12 , the pattern of the ET-1-induced increase in [Ca 2ϩ ] i was different from that in CHO-ET A R and CHO-ET A R⌬385. That is, ET-1 failed to induce an initial transient increase in [Ca 2ϩ ] i , and it induced only a sustained increase in [Ca 2ϩ ] i (Fig. 1C) . The magnitude of the sustained increase in [Ca 2ϩ ] i in CHO-SerET A R was lower than that in CHO-ET A R (Fig. 1E) .
Pharmacological Identification of Ca 2؉ Channels Activated by ET-1 in CHO-ET A R, CHO-ET A R⌬385, and CHO-SerET A R. As described previously (Kawanabe et al., 2001) , in CHO-ET A R, the ET-1-induced sustained increase in [Ca 2ϩ ] i was partially suppressed by the maximally effective concentration (10 M) of either SK&F 96365 or LOE 908, and it was abolished by combined treatment with both block-ers (Fig. 2, A and D) . In CHO-ET A R⌬385, the ET-1-induced sustained increase in [Ca 2ϩ ] i was completely inhibited by 10 M SK&F 96365, whereas LOE 908 at concentrations up to 10 M had no effects (Fig. 2, B and E) . In CHO-SerET A R, the ET-1-induced sustained increase in [Ca 2ϩ ] i was completely inhibited by 10 M LOE 908, whereas SK&F 96365 at concentrations up to 10 M had no effects (Fig. 2, C and F) .
Effects of Inhibition of PLC on the Species of ET-1-Activated Ca 2؉ Channels in CHO-ET A R. In CHOSerET A R, coupling between the receptor and G q is missing, and hence, PLC as an effector of G q cannot be activated upon stimulation of the receptor. To mimic the stimulation in CHO-SerET A R and confirm that PLC actually acts as an effector for activation of Ca 2ϩ channels, we used U73122, a PLC blocker. Previous reports demonstrated that 5 to 10 M U73122 inhibits PLC activation completely (Okamoto et al., 1995; Kanki et al., 2001) . ET-1 stimulated [ 3 H]inositol phosphates (IPs) formation in CHO-ET A R (Kawanabe et al., 2001 ). On the other hand, ET-1 failed to induce [ 3 H]IPs formation in CHO-ET A R treated with 5 M U73122 (data not shown). ET-1 at 10 nM induced only the sustained increase in [Ca 2ϩ ] i in CHO-ET A R treated with 5 M U73122 (Fig. 3, A and B) . The magnitude of the sustained increase in [Ca 2ϩ ] i was approximately 20% of that in the absence of U73122. This sustained increase in [Ca 2ϩ ] i was completely inhibited by 10 M LOE 908, whereas SK&F 96365 at concentrations up to 10 M had no effects (Fig. 3, A and B) . (Kawanabe et al., 2002b) , it is unknown which of the G proteins is involved in the activation of Ca 2ϩ channels. To clarify whether G s was involved in Ca 2ϩ channel activation, we examined the effects of dibutyryl cAMP on the resting [Ca 2ϩ ] i and the ET-1-induced increase in [Ca 2ϩ ] i . A previous report demonstrated that 1 mM dibutyryl cAMP activates protein kinase A in CHO cells (Lee and Fraser, 1993) . Dibutyryl cAMP at 1 mM failed to evoke an increase in [Ca 2ϩ ] i in CHO-SerET A R (Fig. 3C) . Moreover, the ET-1-induced sustained increase in [Ca 2ϩ ] i was not affected by 1 mM dibutyryl cAMP in CHO-SerET A R (Fig. 3D) ] i in CHO-ET A R and CHOSerET A R. In this experiment, G 12 G228A was microinjected into CHO-ET A R and CHO-SerET A R, and the ET-1-induced increase in [Ca 2ϩ ] i in these cells was analyzed using microfluorimetry.
In CHO-ET A R microinjected with G 12 G228A, ET-1 evoked transient and subsequently sustained increase in [Ca 2ϩ ] i . The magnitude of the sustained increase in [Ca 2ϩ ] i was approximately 40% of that in CHO-ET A R microinjected with an expression vector alone (data not shown). The sustained increase in [Ca 2ϩ ] i was inhibited by 10 M SK&F 96365, whereas it remained unaffected by 10 M LOE 908 (Fig. 4A) . ET-1 failed to induce a sustained increase in [Ca 2ϩ ] i in CHOSerET A R microinjected with G 12 G228A (Fig. 4B) .
Discussion
As reported previously (Kawanabe et al., 2001) , the ET-1-induced sustained increase in [Ca 2ϩ ] i in CHO-ET A R results from extracellular Ca 2ϩ influx through three types of VICCs: NSCC-1, NSCC-2, and SOCC. Pharmacological identification of these Ca 2ϩ channels and calculation for contribution of Ca 2ϩ influx through each channel are explained schematically in Fig. 5 . We have pharmacologically defined these channels in CHO cells expressing human recombinant ET A R and VSMCs expressing endogenous ET A R and have found that the same Ca 2ϩ channels are activated in these cells (Kawanabe et al., 2001 (Kawanabe et al., , 2002a .
In CHO-ET A R⌬385, the only Ca 2ϩ channels activated by ET-1 are SOCCs, judging from the sensitivity of the ET-1-induced sustained increase in [Ca 2ϩ ] i to SK&F 96365 and LOE 908 (Fig. 2, B and E) . Because CHO-ET A R⌬385 is coupled with G q but not with G s or G 12 (Kawanabe et al., 2002b) , this result indicates that G q is required (sufficient) for activation of SOCC. Furthermore, activation of SOCC in CHO-ET A R is lost after treatment with U73122 (Fig. 3, A and B) , indicating that PLC acts as an effector downstream of G q . These results, taken together, show that SOCC is activated via a G q /PLC-dependent pathway.
Conversely, the results obtained from CHO-ET A R⌬385 suggest that the activation of NSCC-1 and NSCC-2 requires G proteins other than G q . Because CHO-ET A R is coupled with G s and G 12 in addition to G q (Aramori and Nakanishi, 1992; Kawanabe et al., 2002b) , activation of NSCC-1 and NSCC-2 might be mediated by either G s or G 12 . To address this point, we used CHO-SerET A R, which couples with G s and G 12 but not with G q (Kawanabe et al., 2002b) . In CHOSerET A R, ET-1 activated NSCC-1 but not NSCC-2, because of the pharmacology of the sustained increase in [Ca 2ϩ ] i (sensitive to LOE 908 and resistant to SK&F 96365) (Fig. 3,  C and D) . These results indicate that either G s or G 12 is required for activation of NSCC-1, whereas either G s , G 12 , or both are not sufficient for activation of NSCC-2. Regarding a mechanism for activation of NSCC-1, dibutyryl cAMP alone was without effect in the resting [Ca 2ϩ ] i and the ET-1-induced sustained increase in [Ca 2ϩ ] i in CHO-SerET A R (Fig.  3) , excluding the possibility that activation of NSCC-1 is mediated by cAMP, a product of G s /adenylate cyclase-dependent pathway. Moreover, disruption of signaling through endogenous G 12 by its dominant-negative mutant (G 12 G228A) abrogated activation of NSCC-1 in CHO-SerET A R as well as CHO-ET A R (Fig. 4) , indicating that activation of NSCC-1 is mediated by G 12 . Taken together, these results strongly demonstrate that NSCC-1 is activated via a G 12 -dependent pathway.
As for a mechanism for activation of NSCC-2, the channel was not activated in CHO-ET A R pretreated with U73122 or in CHO-ET A R microinjected with G 12 G228A (Figs. 3 and 4) . These results indicate that both a G q /PLCdependent pathway and a G 12 -dependent pathway are required for activation of NSCC-2. In accordance with this conclusion, NSCC-2 was not activated after the stimulation of ET A R lacking coupling with either G q or G 12 , i.e., SerET A R and ET A R⌬385.
Signaling mechanisms downstream of G proteins are presently unknown. In the case of G q , it is very likely that PLC is activated downstream of G q , considering that CHO-ET A R treated with U73122 (an inhibitor of PLC) mimicked CHOSerET A R (which lost the ability to couple with G q ) in terms of temporal pattern and magnitude of the ET-1-induced changes in [Ca 2ϩ ] i and species of activated channels. Stimulation of PLC leads to increased formation of inositol-1,4,5-trisphosphate and diacylglycerol (DAG). Inositol-1,4,5-trisphosphate acts on its receptor on sarcoplasmic reticulum as an intracellular Ca 2ϩ store to release Ca 2ϩ and subsequently deplete the store (Berridge, 1993) . Thus, the store depletion could be a trigger for activation of the Ca 2ϩ channels on the plasma membrane called capacitative Ca 2ϩ channel (Thasreup et al., 1990) . In fact, SOCC is activated in CHO-ET A R and VSMCs, after depletion of the Ca 2ϩ store by treatment with thapsigargin (an inhibitor of Ca 2ϩ -pump ATPase on the membrane of sarcoplasmic reticulum) (Kawanabe et al., 2001 (Kawanabe et al., , 2002a . The concentrations of ET-1 that failed to induce a transient increase in [Ca 2ϩ ] i and IP accumulation did not induce SOCC activation (Kawanabe et al., 2001) . Judging from these data, we concluded that the transient increase in [Ca 2ϩ ] i (depletion of Ca 2ϩ from intracellular Ca 2ϩ store) essentially follows the characteristics of SOCC. On the other hand, another second messenger, DAG, can directly activate Ca 2ϩ channels such as transient receptor potential (Hofmann et al., 1999) . Thus, DAG might be an effector downstream of G q . In the case of G 12 , several kinds of proteins are reported to be its effectors (Seasholtz et al., 1999) . We have recently shown that stimulation of CHO-ET A R with ET-1 induces actin stress fiber formation through G 12 , and that downstream of G 12 , a small GTP-binding protein Rho and -associated coiled-coil-forming protein kinase is activated (Kawanabe et al., 2002b) . Thus Rho/Rho-associated coiled-coil-forming protein kinase might be a signal downstream of G 12 . Additional study is needed to identify the effectors downstream of G q and G 12 for activation of NSCC-1, NSCC-2, and SOCC.
In summary, stimulation of ET A R with ET-1 activates NSCC-1, NSCC-2, and SOCC in CHO-ET A R. NSCC-1 is activated via a G 12 -dependent pathway, NSCC-2 is activated via G q -and G 12 -dependent pathways, and SOCC is activated via a G q -dependent pathway. 
